NewGenIvf Group (NIVF) Competitors $0.35 -0.01 (-2.59%) Closing price 04:00 PM EasternExtended Trading$0.35 +0.00 (+1.11%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NIVF vs. OTRK, SSY, ATPC, ACON, ATIP, BGLC, VSEE, DHAC, BACK, and BTTXShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Ontrak (OTRK), SunLink Health Systems (SSY), Agape ATP (ATPC), Aclarion (ACON), ATI Physical Therapy (ATIP), BioNexus Gene Lab (BGLC), Vsee Health (VSEE), Digital Health Acquisition (DHAC), IMAC (BACK), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Ontrak SunLink Health Systems Agape ATP Aclarion ATI Physical Therapy BioNexus Gene Lab Vsee Health Digital Health Acquisition IMAC Better Therapeutics Ontrak (NASDAQ:OTRK) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, earnings, valuation, dividends, profitability and media sentiment. Do analysts recommend OTRK or NIVF? Ontrak currently has a consensus target price of $45.00, suggesting a potential upside of 2,940.54%. Given Ontrak's stronger consensus rating and higher possible upside, research analysts clearly believe Ontrak is more favorable than NewGenIvf Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ontrak 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NewGenIvf Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is OTRK or NIVF more profitable? NewGenIvf Group has a net margin of 0.00% compared to Ontrak's net margin of -237.77%. NewGenIvf Group's return on equity of 0.00% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets Ontrak-237.77% -171.34% -113.42% NewGenIvf Group N/A N/A N/A Does the MarketBeat Community prefer OTRK or NIVF? Ontrak received 38 more outperform votes than NewGenIvf Group when rated by MarketBeat users. CompanyUnderperformOutperformOntrakOutperform Votes3859.38% Underperform Votes2640.63% NewGenIvf GroupN/AN/A Which has better valuation & earnings, OTRK or NIVF? NewGenIvf Group has lower revenue, but higher earnings than Ontrak. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOntrak$10.85M0.58-$27.92M-$15.81-0.09NewGenIvf Group$5.14M0.36$130KN/AN/A Which has more volatility & risk, OTRK or NIVF? Ontrak has a beta of 2.93, indicating that its stock price is 193% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.18, indicating that its stock price is 82% less volatile than the S&P 500. Does the media refer more to OTRK or NIVF? In the previous week, NewGenIvf Group had 3 more articles in the media than Ontrak. MarketBeat recorded 4 mentions for NewGenIvf Group and 1 mentions for Ontrak. NewGenIvf Group's average media sentiment score of 0.67 beat Ontrak's score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the news media. Company Overall Sentiment Ontrak Neutral NewGenIvf Group Positive Do institutionals and insiders believe in OTRK or NIVF? 12.9% of Ontrak shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 1.9% of Ontrak shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryNewGenIvf Group beats Ontrak on 8 of the 15 factors compared between the two stocks. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.85M$1.94B$5.44B$7.80BDividend YieldN/A7.15%5.43%4.31%P/E RatioN/A15.4422.1418.40Price / Sales0.363.77389.70101.30Price / Cash3.119.3238.2034.62Price / Book0.163.946.664.18Net Income$130,000.00$87.49M$3.21B$247.71M7 Day Performance23.54%8.22%5.83%6.45%1 Month Performance-66.01%-7.62%-4.32%-3.14%1 Year Performance-98.65%-27.18%17.83%5.40% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf Group1.6514 of 5 stars$0.35-2.6%N/A-98.8%$1.85M$5.14M0.00N/AGap UpOTRKOntrak2.4089 of 5 stars$1.66+5.8%$45.00+2,610.8%-70.9%$7.00M$11.24M-0.16250SSYSunLink Health SystemsN/A$0.85-4.7%N/A+37.7%$5.97M$31.23M6.061,376ATPCAgape ATP0.3331 of 5 stars$1.42+7.6%N/A-56.3%$5.67M$1.32M-1.9540News CoverageGap DownACONAclarion1.6664 of 5 stars$10.00+20.0%$11,758.50+117,485.0%-99.7%$5.07M$49,289.000.007Gap DownHigh Trading VolumeATIPATI Physical TherapyN/A$1.00-1.0%N/A-78.3%$4.46M$741.86M-0.055,600Gap UpBGLCBioNexus Gene Lab0.2692 of 5 stars$2.32-11.8%N/A-51.8%$4.17M$9.26M0.0030Gap DownVSEEVsee Health1.0736 of 5 stars$1.07+2.3%$5.00+367.3%N/A$3.86M$6.38M0.00N/ADHACDigital Health AcquisitionN/A$1.05-4.0%N/A-90.1%$3.77MN/A0.002,021BACKIMACN/A$0.06+21.1%N/A-98.9%$114,000.00$72,050.000.00180Gap UpBTTXBetter TherapeuticsN/A$0.00-50.0%N/A-97.4%$5,000.00N/A0.0040 Related Companies and Tools Related Companies Ontrak Alternatives SunLink Health Systems Alternatives Agape ATP Alternatives Aclarion Alternatives ATI Physical Therapy Alternatives BioNexus Gene Lab Alternatives Vsee Health Alternatives Digital Health Acquisition Alternatives IMAC Alternatives Better Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NIVF) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NIVF Stock Free NIVF Stock Alerts